Abstract:We thank Agilli et al for their interest in our article. They claimed that several factors, including diseases, drugs, and even the way samples are collected, can affect prealbumin serum levels. We agree with their comments. Protein energy malnutrition is a chronic and acute lean body protein loss that leads to a state of specific nutrient deficiency and is associated with a worse outcome during illness and may be reversed by conversion to an anabolic state. Serum prealbumin, a nutritional marker with a short half-life and a rapid synthesis rate, was affected by several factors including some diseases, inflammation, malnutrition, some drugs such as prednisone, and alcohol use. Our current study indicated that the incidence of major adverse events (MAEs) significantly increased in patients with lower levels of serum prealbumin. After adjustment for confounders, serum prealbumin levels emerged as one of the significant predictors of MAEs (death from any cause and further deterioration in renal function requiring chronic dialysis) in patients undergoing peripheral arterial angiography. In this cohort study, we excluded patients with multiple myeloma and the use of nonsteroidal anti-inflammatory drugs or corticosteroids. There was no significant difference between patients with and without MAEs in current drinking (P1⁄4 .620). This result was consistent with previous studies which evaluated prealbumin levels in patients after peripheral arterial angiography. Several studies suggested that malnutrition has a negative impact on the prognosis in patients with acute kidney injury (AKI) or heart failure. The meta-analysis provided evidence that hypoalbuminemia is a significant independent predictor of death following AKI development. According to Valdivieso et al, serum prealbumin levels <11 mg/dL were strongly associated with increased in-hospital mortality (hazard ratio, 2.10; 95% confidence interval, 1.08-4.08), compared to patients with the same AKI severity and treatment but with a serum prealbumin level 11 mg/dL. In addition, each increment of 5 mg/dL of serum prealbumin was associated with an adjusted 29% decrease in in-hospital morality. In a heart failure study, patients with discharge prealbumin 15 mg/dL had a higher 6-month morbidity and mortality. Similarly, in our previous study, a lower level of prealbumin was found to be significant in patients with hospital-acquired AKI who died within 28 days compared to those who survived >28 days (12.5 + 5.9 vs 16.4 + 6.9 mg/dL, P 1⁄4 .001). Furthermore, we are conducting another study to assess the impact of serum prealbumin level on prognosis of patients with AKI after coronary artery bypass graft operation. The results also show an independent association between lower prealbumin level and mortality. In conclusion, serum prealbumin could be an independent predictor of MAEs in AKI. Its serum levels should always be interpreted in light of the influencing factors, among which are concomitant disease, the inflammatory state, and liver function.

Lower Serum Albumin Level Is Associated With an Increased Risk for Loss of Residual Kidney Function in Patients Receiving Peritoneal Dialysis

The Association Between Albumin and Mortality in Patients with Acute Kidney Injury: a Retrospective Observational Study

Serum albumin changes and mortality risk of peritoneal dialysis patients

Factors influencing serum albumin in peritoneal dialysis patients

Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis

Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease

The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy

Impact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration

C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

Impact of Prealbumin Levels on Patients with Acute Kidney Injury

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent

Association of hypoalbuminemia with hospitalization and mortality in hemodialysis patients with COVID‐19

High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study

Low Serum Albumin Levels are Associated with Short-Term Recurrence of Arteriovenous Fistula Failure

Residual Kidney Function and Cause-Specific Mortality Among Incident Hemodialysis Patients

Association Between Serum Albumin and Mortality in Dialysis Patients Is Partly Explained by Inflammation, and Not by Malnutrition

Risk Factors for Loss of Residual Renal Function in Children with End-Stage Renal Disease Undergoing Automatic Peritoneal Dialysis

Does Loss Of Residual Renal Function Lead To Malnutrition In Peritoneal Dialysis Patients?

Relationship Between Serum Albumin and Pulse Wave Velocity in Patients on Continuous Ambulatory Peritoneal Dialysis